Maryland
Phase 1 cancer trials in Maryland
91 Phase 1 cancer studies are recruiting participants at sites in 9 cities across Maryland as of November 17, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Maryland city with a recruiting study
By research area: Lung Cancer (31), Lymphoma (26), Breast Cancer (16), Prostate Cancer (12), Pancreatic Cancer (5), Melanoma (1).
Baltimore (50), Bethesda (30), Glen Burnie (7), Calverton (2), Rockville (2), Annapolis (1), Bel Air (1), Silver Spring (1), Towson (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Maryland
Basic details from each study's public record (the 12 most recently updated of 91). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- Phase 1
- Ages 12 to 120
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda
- Registry record
- NCT04222413 · updated
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
- Phase 1
- Ages 18 and older
- Female participants
- Sponsor
- Totus Medicines
- Recruiting in
- Calverton
- Registry record
- NCT05683418 · updated
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Aktis Oncology, Inc.
- Recruiting in
- Glen Burnie
- Registry record
- NCT07020117 · updated
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Stemline Therapeutics, Inc.
- Recruiting in
- Baltimore
- Registry record
- NCT06638307 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Maryland on ClinicalTrials.gov.
Lung cancer: recently updated in Maryland
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Baltimore
- Registry record
- NCT06287775 · updated
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
- Phase 1
- Ages 18 to 120
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda
- Registry record
- NCT06066138 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Recruiting in
- Baltimore
- Registry record
- NCT07020221 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Maryland on ClinicalTrials.gov.
Prostate cancer: recently updated in Maryland
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
- Phase 1/2
- Ages 18 to 120
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda
- Registry record
- NCT07667400 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Maryland on ClinicalTrials.gov.
Lymphoma: recently updated in Maryland
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Recruiting in
- Baltimore
- Registry record
- NCT04726241 · updated
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
- Early Phase 1
- Ages 18 to 100
- All sexes
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Recruiting in
- Bethesda
- Registry record
- NCT07428707 · updated
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Phase 1
- Ages 18 to 120
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda
- Registry record
- NCT07572136 · updated
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- Phase 1/2
- Ages 18 to 120
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda
- Registry record
- NCT03223610 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Maryland on ClinicalTrials.gov.
Ask about studies in Maryland
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections